What questions should I ask my oncologist about metastatic Colorectal Cancer

Key Questions to Ask Your Oncologist About Metastatic Colorectal Cancer

I'm glad you're preparing for this conversation. Asking informed questions helps you and your care team make the best decisions together. Here are the most important areas to explore:

1. UNDERSTANDING YOUR SPECIFIC DISEASE

Start with the basics about YOUR cancer:

• "Where exactly has my cancer spread? (liver, lungs, other organs?)"
• "Is my disease resectable (surgically removable) or unresectable (not able to be removed)?"
• "What stage is my cancer, and what does that mean for my treatment options?"
• "Has my tumor been tested for specific mutations (KRAS, NRAS, BRAF, HER2)? What were the results?"
• "What is my tumor's MMR/MSI status?" (This determines if immunotherapy might work)

Why this matters: According to NCCN Guidelines for Colon Cancer, treatment decisions heavily depend on whether your metastases can be surgically removed and what genetic mutations your tumor has. These factors determine which drugs will actually work for you.

---

2. TREATMENT OPTIONS & APPROACH

Ask about the overall strategy:

• "What is the goal of my treatment—to cure, control, or manage symptoms?"
• "If my cancer is unresectable now, could chemotherapy shrink it enough to make surgery possible later?"
• "What are my treatment options, and why do you recommend [specific option] for me?"
• "How often will I receive treatment, and for how long?"

Ask about specific therapies:

• "Will I receive chemotherapy? If so, which regimen (FOLFOX, CAPEOX, FOLFIRI, FOLFIRINOX)?"
• "Am I a candidate for targeted therapy or immunotherapy based on my tumor's genetic profile?"
• "If I have a BRAF mutation, would encorafenib plus an EGFR inhibitor be appropriate?"
• "Could bevacizumab (Avastin) or other biologic therapies help in my case?"

Why this matters: NCCN Guidelines show that metastatic colorectal cancer treatment varies dramatically based on tumor genetics and resectability. For example, patients with wild-type (normal) KRAS/NRAS/BRAF and left-sided tumors may benefit from EGFR inhibitors, while those with BRAF mutations need different approaches.

---

3. SURGERY & LOCAL TREATMENTS

If your metastases might be removable:

• "Should I have surgery to remove my primary tumor and/or metastases?"
• "If I have liver metastases, am I a candidate for liver resection?"
• "What about lung metastases—could those be surgically removed?"
• "Would I need chemotherapy before surgery (neoadjuvant) or after (adjuvant)?"
• "Are there other options like ablation or radiation instead of surgery?"

Why this matters: NCCN Guidelines emphasize that selected patients with resectable metastatic disease can achieve long-term survival—even cure—with surgery combined with chemotherapy. This is a critical conversation because resectability changes everything about your treatment plan.

---

4. SIDE EFFECTS & MANAGING TREATMENT

Understand what to expect:

• "What side effects are most common with my treatment plan?"
• "Which side effects should I report immediately versus manage at home?"
• "Will I experience neuropathy (nerve damage/numbness)? How is that managed?"
• "How will treatment affect my daily life—work, exercise, diet?"
• "Are there supportive medications or therapies to help manage side effects?"

Why this matters: Different chemotherapy regimens cause different side effects. Knowing what's coming helps you prepare and report problems early.

---

5. MONITORING & FOLLOW-UP

Ask about how progress will be tracked:

• "How often will I have imaging scans (CT, MRI, PET)?"
• "Will you monitor my CEA (tumor marker) blood levels?"
• "How will we know if the treatment is working?"
• "What happens if my cancer progresses on this treatment?"
• "What's the plan for second-line therapy if needed?"

Why this matters: NCCN Guidelines recommend regular imaging every 2-3 months during active treatment for metastatic disease. Understanding the surveillance plan helps you know what to expect.

---

6. CLINICAL TRIALS & NEWER OPTIONS

Ask about research opportunities:

• "Are there clinical trials I might be eligible for?"
• "Are there newer drugs or combinations that might be appropriate for my situation?"
• "What emerging biomarkers or tests might help guide my treatment?"

Why this matters: Clinical trials can offer access to newer therapies and more intensive monitoring. Your oncologist can help determine if you're a candidate.

---

7. PROGNOSIS & REALISTIC EXPECTATIONS

Have an honest conversation:

• "What is my prognosis with this treatment plan?"
• "What factors most influence my outcome?"
• "What does 'response to treatment' look like for someone in my situation?"
• "How will we define success in my case?"

Why this matters: Understanding realistic expectations helps you make informed decisions and plan accordingly. Your doctor can explain what's possible based on your specific situation.

---

8. QUALITY OF LIFE & SUPPORTIVE CARE

Don't forget the whole picture:

• "What supportive services are available (nutrition, counseling, support groups)?"
• "Should I see a palliative care specialist?" (This helps manage symptoms and side effects—it's not just end-of-life care)
• "Are there lifestyle changes that might help my treatment work better?"
• "How do I manage fatigue, pain, or other ongoing symptoms?"

Why this matters: NCCN Guidelines emphasize that supportive care is part of your treatment plan, not separate from it.

---

9. BRING THESE TO YOUR APPOINTMENT

Make it easier to remember:

• Write down your questions beforehand
• Bring a notebook or use your phone to take notes
• Consider bringing a trusted family member or friend to listen and help remember details
• Ask for written summaries of your treatment plan
• Request copies of your pathology report and imaging results

---

A SAMPLE OPENING

Here's how you might start the conversation:

"I want to understand my situation as fully as possible so we can work together on the best plan. Can you walk me through what my test results show about my cancer, and then explain the treatment options you're recommending?"

---

KEY TAKEAWAY

According to NCCN Guidelines for Colon Cancer, treatment of metastatic colorectal cancer is highly individualized based on:

• Where the cancer has spread (liver, lungs, other organs)
• Whether it's resectable (can be surgically removed)
• Tumor genetics (KRAS, NRAS, BRAF, HER2, MMR/MSI status)
• Your overall health and functional status

Your oncologist needs to know you're engaged and want to understand your disease. These questions show you're ready to be an active partner in your care.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.